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Lon proteaseMitochondrial proteostasis depends on a hierarchical system of tightly controlled quality surveillance mech-
anisms. Proteases within mitochondria take center stage in this network. They eliminate misfolded and dam-
aged proteins and ensure the biogenesis and morphogenesis of mitochondria by processing or degrading
short-lived regulatory proteins. Mitochondrial gene expression, the mitochondrial phospholipid metabolism
and the fusion of mitochondrial membranes are under proteolytic control. Furthermore, in response to stress
and mitochondrial dysfunction, proteolysis inhibits fusion and facilitates mitophagy and apoptosis. Deﬁning
these versatile activities of mitochondrial proteases will be pivotal for understanding the pathogenesis of var-
ious neurodegenerative disorders associated with defective mitochondria-associated proteolysis. This article
is part of a Special Issue entitled: Mitochondrial dynamics and physiology.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Mitochondria are essential organelles housing the respiratory
chain complexes, which generate most of the cellular energy. They
are the sites of many biosynthetic events, buffer cellular calcium
and play an integral role in numerous cellular signaling pathways in-
cluding programmed cell death [1–4]. Dysfunction of mitochondria is
detrimental to cellular viability, has been linked to many diseases,
and is associated with aging [5,6].
Recent proteomics and bioinformatics approaches deﬁned a compre-
hensive inventory of mitochondrial proteins [7,8]. Numerous cellular
pathways are emerging that maintain the mitochondrial proteome, en-
suring a healthy and functional mitochondrial network. These pathways
counteract themany challenges thatmitochondria face and thatmay in-
ﬂuence theirwell-being. Theﬁrst challenge arises from the unique prop-
erty of the organelle in that their proteome is encoded by two distinct
genomes.While the vastmajority ofmitochondrial proteins are encoded
by nuclear genes and synthesized in the cytosol, mitochondria also har-
bor their owngenome, encoding for 13 polypeptides inmammalian cells
(8 in yeast). All mitochondrial-encoded proteins constitute core compo-
nents of the respiratory chain complexes. In order to achieve efﬁcient
respiratory chain complex assembly, it is imperative that there is coordi-
nated expression and import of nuclear-encoded proteins to assembleMitochondrial dynamics and
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rights reserved.with themitochondrial-encoded proteins. Failure to coordinate this pro-
cess may result in unpartnered proteins that are prone to misfolding or
aggregation. The second challenge imposed upon mitochondria arises
due to production of reactive oxygen species (ROS), which is an inevita-
ble byproduct of the generation of ATP through oxidative phosphoryla-
tion. ROS can react with proteins, DNA and lipids resulting in
accumulation of oxidatively damaged products. Hence, mitochondrial
proteins, lipids and DNA are more prone to oxidative damage, which
can lead to depolarization of the mitochondrial inner membrane. This
may ultimately trigger the permeabilization of the outer membrane,
the release of pro-apoptotic proteins from the intermembrane space
into the cytosol and the initiation of the apoptotic cascade [9,10].2. Mitochondrial quality control at a glance
In order to maintain a functional mitochondrial network, elabo-
rate quality control mechanisms have evolved that remove damaged
proteins or sequester and remove damaged organelles (Fig. 1)
[11–15]. Impaired quality control of mitochondria is detrimental to
cell health and has been linked to aging and various diseases, includ-
ing prevalent neurological disorders like Parkinson's disease and spi-
nocerebellar ataxia, highlighting the relevance of these defense
pathways for cellular homeostasis and survival [16].
Mitochondrial proteases and the cytosolic ubiquitin–proteasome
system (UPS) comprise the ﬁrst line of cellular defense by facilitating
the removal of damaged, oxidized or misfolded mitochondrial pro-
teins (Figs. 1A and 2). Two membrane-bound AAA protease com-
plexes conduct quality control surveillance across the mitochondrial
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towards the matrix and the i-AAA protease towards the intermembrane
space. Additional peptidases, such as themetallopeptidase OMA1, extend
the capacity of this proteolytic system and contribute to the quality
control of inner membrane proteins [18,19]. The Lon protease (Pim1 in
yeast) eliminates denatured or oxidatively damaged proteins from the
mitochondrial matrix [20–22]. Substrates of another matrix-localized
peptidase, the ClpXP protease, remain to be identiﬁed. ClpXP from
Caenorhabditis elegans is involved in the mitochondrial unfolded protein
response (mtUPR), a compartment-speciﬁc stress response, regulating
the levels of mitochondrial proteases and molecular chaperones to
accommodate the unfolded protein load [23–25]. In addition to proteases
localized within mitochondria, it is becoming clear that the cytosolic UPS
also contributes to mitochondrial quality control (Fig. 2). Mitochondrial
proteins that become mistargeted or misfolded en route to mitochondria
are recognized and removed by the UPS [26,27]. Moreover, the UPS
degrades proteins residing in the outer membrane of mitochondria in a
process resembling ER-associated protein degradation (ERAD) and is
therefore referred to as OMMAD (Fig. 2) (for outer mitochondrial
membrane-associated degradation) [26,28].
Mitochondria are highly dynamic organelles, constantly undergoing
ﬁssion and fusion events. This property of mitochondria offers a second
line of defense against mitochondrial dysfunction (Fig. 1B) [29,30]. Mito-
chondrial fusion allows content mixing helping organelles deﬁcient in
certain components to replenish their stores (Fig. 1Bii) [31–33]. Consis-
tently, mtDNA mutations accumulate upon inhibition of fusion, ﬁnally
triggering the loss of themitochondrial genome [32].Moreover, themito-
chondrial network becomes hyper-fused under certain stress conditions,
for instance upon starvation, following inhibition of autophagy or protein
synthesis and under oxidative stress conditions (Fig. 1Bii) [34–36]. This
protects mitochondria against autophagy and increases cellular ATP pro-
duction [35,36]. However, severe mitochondrial damage can trigger loss
of the membrane potential across the mitochondrial inner membrane,
which impairs mitochondrial fusion. Ongoing ﬁssion events then result
in fragmentation of the mitochondrial network, a prerequisite for the
mitochondria-speciﬁc form of autophagy [37], termed mitophagy [38],
which represents another important form of mitochondrial quality con-
trol (Fig. 1Bi). Therefore, the fragmentation of mitochondria facilitates
the segregation of damaged organelles from the healthy network andSegragation and 
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to lysosomes for degradation. QC, quality control.their removal by mitophagy. Moreover, fragmentation of the mitochon-
drial network precedes programmed cell death [28,39,40]. Although the
precise reason that mitochondria fragment during apoptosis remains
undeﬁned, perhaps this facilitates the release of pro-apoptotic compo-
nents ensuring turnover of cells unable to cope with high levels of mito-
chondrial dysfunction.
Recently, mitochondrial-derived vesicles (MDVs) were reported to
facilitate mitochondrial quality control by delivery of selective mito-
chondrial cargo to lysosomes (Fig. 1Biii) [41–43]. These MDVs are gener-
ated as an early response to oxidative stress [41]. Their formation and
delivery to lysosomes does not require mitochondrial depolarization or
Drp1-mediated mitochondrial ﬁssion and is independent of the general
autophagy machinery [41]. These ﬁndings suggest a quality control
route parallel tomitophagy for the selective degradation ofmitochondrial
proteins in lysosomes.
While the complexity of mitochondrial quality control mechanisms is
unfolding, it is becoming increasingly clear that mitochondrial proteases
take center stage in these pathways. In addition to their conventional
role in degrading damaged or misfolded mitochondrial proteins, many
proteases have additional functions as processing peptidases and control
the stability of proteins that regulate crucial steps during mitochondrial
biogenesis, morphogenesis and turnover (Fig. 3). In this review, we
describe how proteolysis can inﬂuence various mitochondrial functions
and can impinge on mitochondrial quality control.
3. Proteolytic control of mitochondrial biogenesis
3.1. Lon protease regulates mitochondrial transcription
Lon is an ATP-dependent serine protease found in the mitochondrial
matrix that mediates the degradation of misfolded and oxidatively
damaged proteins [20–22]. It has also been recently illustrated that Lon
plays a pivotal role in the regulation of mitochondrial gene expres-
sion [44,45]. In yeast, Lon/Pim1 is required for the expression of
intron-containing genes encoded by mitochondrial DNA (mtDNA), in-
cluding cytochrome c oxidase subunit 1 and cytochrome b [46]. In
Drosophila cells, depletion of Lon increases the protein levels ofmitochon-
drial transcription factor A (TFAM) andmtDNA copy number, resulting in
enhanced transcription of mtDNA-encoded genes [44,47]. When theg
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Fig. 2. The cytosolic UPS contributes to mitochondrial quality control. The vast majority of mitochondrial proteins are synthesized on cytosolic ribosomes. Newly synthesized pro-
teins are either efﬁciently imported into mitochondria (bold line) or degraded by the UPS if they are mistargeted or misfolded prior to import (dashed line). Proteins present in the
outer mitochondrial (OM) membrane can be ubiquitylated (Ub) and degraded by a cascade of E1, E2 and E3 enzymes. The proteolysis of OM proteins shares similarities with the
turnover of ER membrane proteins but the detailed mechanism remains to be elucidated (indicated by ?). TOM, protein translocase of the outer membrane; IMS, intermembrane
space.
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mtDNA ratio and to control the rate of mitochondrial transcription. As a
corollary, TFAM is not degraded upon depletion of mtDNA in cells lacking
Lon, resulting in increased TFAM:mtDNA ratio and inhibition of mtDNA
transcription [47]. The cellular levels of TFAM vary in concert with Lon
levels, suggesting that Lon-mediated degradation of TFAM levels may ad-
justmtDNA levels and concomitantlymtDNA transcription under physio-
logical conditions [44,45,47]. It remains to be determined whether this
regulatory circuit explains early observations that Lon can bind both
DNA and RNA in vitro [48,49].3.2. The m-AAA protease controls mitochondrial translation
Another protease regulating mitochondrial gene expression is the
m-AAA protease, a central component of the protein quality control sys-
tem in the mitochondrial inner membrane. The m-AAA protease
consists of six subunits, each harboring an ATPase domain and a proteo-
lytic domain. Mutations in subunits of the m-AAA protease, AFG3L2 and
paraplegin, are associated with various neurological disorders, including
spinocerebellar ataxia, hereditary spastic paraplegia and a spastic ataxia
neuropathy syndrome [50–52]. Them-AAA protease degrades misfolded
and non-assembled proteins that are integrated or peripherally associat-
edwith the innermembrane.Moreover, the yeastm-AAA protease serves
as a processing peptidase mediating the maturation of newly imported
MrpL32, a nuclear-encoded subunit of the large mitochondrial ribosome
[53,54]. Yeast cells lacking them-AAA protease accumulate the precursor
form of MrpL32, which does not assemble into mitochondrial ribosomes,
inhibiting mitochondrial translation. The dual activity of the m-AAAprotease as a processing peptidase and quality control enzyme degrading
misfolded polypeptides to peptides raises the intriguing questionwhy the
m-AAAprotease does not completely degrade particular substrates. In the
case of MrpL32, the m-AAA protease initiates proteolysis from the
N-terminus, however stable folding of a cysteine-rich domain prevents
further degradation after the maturation site [53]. Mutations in MrpL32
that destabilize the tightly folded domain result in the complete degrada-
tion of MrpL32 by them-AAA protease.
MrpL32 processing by the m-AAA protease and its requirement for
the synthesis ofmitochondrially encoded respiratory chain subunits ex-
plains the respiratory deﬁciency of yeast cells lacking them-AAA prote-
ase. Indeed, targeting MrpL32 to mitochondria by a heterologous
presequence that is cleaved off by the generalmitochondrial processing
peptidase restores respiratory growth of m-AAA protease deﬁcient
yeast cells, demonstrating that MrpL32 processing represents the cen-
tral function of them-AAA protease in yeastmitochondria [54]. Notably,
MrpL32maturation andmitochondrial translationwas impaired in liver
mitochondria of amousemodel for hereditary spastic paraplegia caused
by the loss of the m-AAA protease subunit paraplegin, suggesting that
impairedmitochondrial translation may contribute to the pathogenesis
of this neurodegenerative disorder [54,55].3.3. Mitochondrial proteases regulate the phospholipid metabolism
The functional integrity of mitochondrial membranes depends on
the coordinated supply of proteins and membrane lipids. These lipids
often exert speciﬁc functions in mitochondrial biogenesis [3]. For in-
stance, the dimeric glycerophospholipid cardiolipin (CL), the signature
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Fig. 3. Versatile activities of i-AAA proteases. ATP-dependent proteases within mitochondria have versatile activities as exempliﬁed by the i-AAA protease. (A) i-AAA proteases reg-
ulate the mitochondrial morphology by proteolytic processing of the dynamin-like GTPase OPA1 in the mitochondrial inner membrane. After import of newly synthesized OPA1
precursor proteins via the TOM and TIM translocases, the mitochondrial targeting sequence of OPA1 is cleaved off by the mitochondrial processing peptidase (MPP) generating
long OPA1 forms (L-OPA1). Approximately half of the L-OPA1 molecules are converted into short OPA1 forms (S-OPA1) by proteolytic processing at site S1 by OMA1 and at site
S2 by the i-AAA protease. Both L- and S-OPA1 are required for mitochondrial fusion. (B) i-AAA proteases determine the stability and completely degrade Ups1 and Ups2, which
regulate the accumulation of cardiolipin and phosphatidylethanolamine, respectively. Ups1/2 are unstable proteins that are degraded by the i-AAA protease if they do not assemble
with Mdm35 in the intermembrane space. (C) i-AAA proteases completely degrade misfolded or damaged proteins to peptides. TOM, protein translocase of the outer membrane;
TIM, protein translocase of the inner membrane; IMS, intermembrane space; MPP, mitochondrial processing peptidase.
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tochondrial genome, the respiratory chain complexes and the protein
translocases. Furthermore, CL also affects mitochondrial fusion and
the activation of apoptosis [3,56–58].Mutations in tafazzin, amitochon-
drial transacylase for CL synthesis, are associated with Barth syndrome
highlighting the importance of CL in maintaining mitochondrial func-
tions [59–61].
Increasing evidence points to a central role of proteases for the
maintenance of the lipid composition of mitochondrial membranes.
A conserved regulatory circuit in the intermembrane space deter-
mines the levels of CL and of phosphatidylethanolamine (PE) in the
mitochondrial membranes [62]. Central components of this regulon
are Ups1 and Ups2, members of the conserved family of Ups1/
PRELI-like proteins [63,64], which ensure the accumulation of CL
and PE, respectively (Fig. 3B) [65,66]. Both proteins are intrinsically
unstable and subjected to turnover if they do not assemble with
Mdm35 in the intermembrane space [66]. The i-AAA protease, a
homo-oligomeric proteolytic complex composed of Yme1 subunits
[67], degrades both Ups1 and Ups2, while the stability of Ups1 is ad-
ditionally affected by the inner membrane peptidase Atp23 [62].
Moreover, the i-AAA protease was found to determine the stability
of phosphatidylserine decarboxylase 1 (Psd1) [68], which mediates
the conversion of phosphatidylserine into PE in the inner membrane.
The i-AAA protease thus appears to affect the composition of mito-
chondrial membranes in multiple ways.
The Lon protease affects the biosynthesis of steroid hormones in
cells of the adrenal cortex, placenta and gonads, as it degrades the ste-
roidogenic acute regulatory protein (StAR) [69,70]. StAR facilitates
the transfer of cholesterol from the outer to the inner mitochondrialmembrane, making it available for steroid hormone synthesis [71].
StAR is thought to release cholesterol to the outer membrane and is
subsequently degraded rapidly upon import into the mitochondrial
matrix. Lon has been identiﬁed as the primary peptidase degrading
StAR [69,70,72]. It is conceivable that the release of its substrate im-
pairs refolding of StAR in the matrix, which is degraded as a misfolded
polypeptide by Lon. Alternatively, Lon might speciﬁcally recognize
StAR and initiates proteolysis at hydrophobic amino acids that are
surface exposed and situated within a highly charged environment
[73].
3.4. Presequence processing regulates mitochondrial protein stability
Themajority of matrix-localized proteins contain an N-terminal, am-
phipathic presequence that is enriched in positively charged amino
acids and ensures correct targeting [74–76]. Most of these presequences
are cleaved off by mitochondrial processing peptidases, MPP, upon im-
port into mitochondria and degraded [77]. Some mitochondrial
preproteins are further processed by additional peptidases. Icp55 (Inter-
mediate cleaving peptidase 55) cleaves a single amino acid from a pre-
cursor protein, whereas Oct1 (Octapeptidyl aminopeptidase 1) has been
reported to remove an octapeptide [78–80]. Recent ﬁndings showed an
unexpected link of these processing events to a protein's half-life
[78–80]. Icp55 and Oct1 act speciﬁcally on those intermediates, which
expose N-terminal amino acids upon processing by MPP that are
destabilizing according to the N-end rule [78–80]. The N-end rule has
been originally deﬁned for bacterial proteins and links the half-life of a
protein to the type of the N-terminal amino acid [81,82]. Accordingly,
processing by Icp55 and Oct1 was found to increase the half-life of
Fig. 4. Proteolytic control of mitochondrial morphogenesis and turnover. (A) Mitochondrial fusion depends on the balanced formation of L- and S-OPA1. In healthy mitochondria,
approximately half of L-OPA1 molecules are converted to S-OPA1 by proteolytic processing. A fraction of L-OPA1 is processed at S2 site by the i-AAA protease and at the S1 site by
OMA1 (constitutive cleavage). Stress conditions or mitochondrial dysfunction (e.g. dissipation of Δψ) activate OMA1 which mediates the complete conversion of L-OPA1 to S-OPA1
and inhibits fusion. (B) Regulation of mitophagy by PINK1. Newly synthesized PINK1 is transported across the outer membrane via the TOM complex and inserted in the inner
membrane in a Δψ-dependent manner. Upon import, the mitochondrial processing peptidase cleaves off the targeting sequence. Subsequent processing of PINK1 by the rhomboid
protease PARL generates a 52 kDa fragment that is further degraded by a MG132-sensitive, yet to be identiﬁed protease. Mitochondrial depolarization inhibits PINK1 import and
degradation but does not interfere with the targeting of newly synthesized PINK1 molecules to mitochondria. PINK1 accumulates on the OM membrane and associates with the
TOM complex. PINK1 present at the mitochondrial surface can recruit Parkin and initiate mitophagy. TOM, protein translocase of the outer membrane; TIM, protein translocase
of the inner membrane; IMS, intermembrane space; Δψ, membrane potential; MPP, mitochondrial processing peptidase.
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trol mechanism for newly imported proteins.
3.5. Regulation of mitochondrial dynamics by proteolysis
Mitochondria form reticular networks, which are maintained by fu-
sion and ﬁssion eventsmediated by conserved dynamin-like GTPases in
both themitochondrial inner and outermembrane [29,30]. Outermem-
brane fusion depends on mitofusin 1 (Mfn1) and mitofusin 2 (Mfn2),
while OPA1 (Mgm1 in yeast) is required for the fusion of the inner
membrane. The dynamin related protein 1 (Drp1) (Dnm1 in yeast)me-
diates mitochondrial ﬁssion. It has been well documented that the sta-
bility and activity of these dynamin-like GTPases is tightly controlled by
proteolysis.3.6. Ubiquitylation determines the accumulation of mitofusins
Studies in yeast and mammalian cells revealed that proteolysis reg-
ulates the steady state protein level of mitofusins, allowing fusion to
proceed. In yeast, the mitofusin Fzo1 interacts with Mdm30, an F-box
protein associated with the Skp1-Cdc53-Fbox (SCF) ubiquitin ligase
complex [83–87]. Mdm30 regulates mitochondrial fusion by mediating
Fzo1 ubiquitylation and degradation in an F-box-dependent manner.
Fzo1 ubiquitylation and degradation occurs only after trans tethering
and GTP hydrolysis and ongoing Mdm30-dependent degradation of
Fzo1 is important for outer mitochondrial membrane fusion [83,84].
Ubiquitylation and clearance of Fzo1 might overcome the steric hin-
drance imposed by a tethering structure to facilitate membrane close-
ness for efﬁcient fusion of the two membranes.
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gases Parkin (see below) and March5/MITOL. Depletion of March5/
MITOL that ubiquitylates Mfn1 induces highly interconnected and
elongated mitochondria and increased senescence [88–91]. The sig-
niﬁcantly increased level of Mfn1 (but not of Mfn2) in cells depleted
of March5/MITOL suggests Mfn1 is a target of March5/MITOL-depen-
dent proteasomal degradation [90]. Consistently, expression of a
GTPase deﬁcient mutant of Mfn1 in March5/MITOL-depleted cells can
restore a reticular mitochondrial morphology and reverts cellular se-
nescence phenotypes [90]. However, the physiological role of March5/
MITOL-mediated degradation of Mfn1 remains elusive. As March5/
MITOL also affects trafﬁcking of Drp1, it is possible that it serves as an
upstream regulator of mitochondrial dynamics [88,90].
3.7. Regulation of Drp1 and mitochondrial ﬁssion by proteolysis
The cytosolic dynamin-like GTPase Drp1 mediates mitochondrial
ﬁssion. Drp1 translocates to the sites of mitochondrial ﬁssion
[92,93], where it self-assembles into ring-shaped oligomers around
the mitochondrial constriction site and uses energy from GTP hydro-
lysis to divide mitochondria [94]. The steady state levels of Drp1 and
its activity is under the control of various posttranslational modiﬁca-
tions, including ubiquitylation, sumoylation, nitrosylation and phos-
phorylation [95].
The E3 ubiquitin ligase March5/MITOL ubiquitylates Drp1 [89,91].
However, unlike Mfn1, ubiquitylation of Drp1 does not trigger its
degradation but rather regulates its activity [90]. Although, the levels
of Drp1 remain unchanged upon downregulation or overexpression
of March5/MITOL, the trafﬁcking of Drp1 to mitochondria is affected
upon overexpression of mutant variant of March5/MITOL harboring
a mutation in the E3-RING domain [88]. The mechanism how
March5/MITOL affects Drp1 remains to be elucidated and it is possible
that March5/MITOL might regulate degradation of another mitochon-
drial protein that in turn affects Drp1 trafﬁcking.
Drp1 is also a substrate of the mitochondrial E3 SUMO ligase MAPL
[96]. Fluorescently tagged SUMO1 (YFP:SUMO) co-localizes with en-
dogenous Drp1, and is found at sites of mitochondrial ﬁssion and at
the tip of fragmented mitochondria [97]. Overexpression of MAPL or
downregulation of the SUMO protease SENP5 results in hyper-
sumoylation of Drp1 andmitochondrial fragmentation [96,98]. Deple-
tion of MAPL, on the other hand, leads to reduced levels of Drp1
suggesting that sumoylation protects Drp1 against degradation
[96,97]. However, mitochondrial morphology is not grossly affected
under these conditions, suggesting that MAPL is not essential for mi-
tochondrial ﬁssion. It is conceivable that MAPL equally affects both
ﬁssion and fusion, as its downregulation also results in reduced
rates of fusion [96].
3.8. Processing of OPA1 by mitochondrial proteases
The fusion of the mitochondrial inner membrane and cristae mor-
phogenesis depends on the dynamin-like GTPase OPA1 (Mgm1 in
yeast), which is anchored to the inner membrane by a single trans-
membrane domain with the bulk of the protein facing the mitochon-
drial intermembrane space [99–102]. Approximately half of the long
(L-) OPA1 molecules are cleaved to generate short (S-) OPA1 forms
that lack the transmembrane anchor (Fig. 4A) [101]. L- and S-OPA1
forms assemble together in a CL-dependent manner, which stimu-
lates OPA1 GTPase activity [103]. The balanced accumulation of L-
and S-OPA1 forms is a prerequisite for the function of OPA1 in fusion
and cristae morphogenesis [104–106], which are thus both under
proteolytic control.
The yeast homologue of OPA1, Mgm1, is processed by the rhom-
boid type protease Pcp1 in the inner membrane to yield one long
and one short form [104,107]. Interestingly, Mgm1 cleavage was
found to depend on cellular ATP levels [108]. It was thereforeproposed that nucleotide dependent Mgm1 processing acted as an
energetic sensor to regulate mitochondrial fusion through the bal-
anced formation of both Mgm1 isoforms. In mammalian cells, the sit-
uation is more complex due to the presence of eight OPA1 splice
variants, which are expressed in a tissue-speciﬁc manner, and two
processing sites [105]. Alternate splicing can occur at exons 4, 4b
and 5b and proteolytic cleavage at sites S1 and S2 encoded by exons
5 and 5b, respectively [105]. Newly synthesized OPA1 precursor mol-
ecules are targeted to mitochondria by an N-terminal mitochondrial
targeting sequence that is cleaved off upon import into mitochondria
generating L-OPA1. Subsequent processing results in the accumula-
tion of three different short forms, which assemble with two long
forms (constitutive cleavage) (Fig. 4A). Different cellular insults that
result in mitochondrial dysfunction induce the complete cleavage of
L-OPA1 to S-OPA1 (stress-induced cleavage) (Fig. 4A). Such stresses
include decreased ATP levels, loss of mtDNA, dissipation of the
mitochondrial membrane potential and induction of apoptosis.
Stress-induced OPA1 processing occurs exclusively at the site S1. Mi-
tochondrial fusion is inhibited under these conditions due to the lack
of L-OPA1 and ongoing ﬁssion events cause fragmentation of the mi-
tochondrial network [109–111]. Stress-induced OPA1 processing is
emerging as a central mechanism to monitor mitochondrial integrity
and conduct quality surveillance, as mitochondrial fragmentation is
associated with mitophagy and apoptosis.
Various mitochondrial proteases were screened for their role in
OPA1 processing. The rhomboid protease PARL is orthologous to
yeast Pcp1 and therefore was considered to be the prime candidate
that mediates OPA1 processing. However, mouse embryonic ﬁbro-
blasts (MEFs) lacking PARL fail to show any difference in mitochon-
drial morphology or in OPA1 processing, suggesting that PARL does
not directly process OPA1 [112,113]. In contrast, depletion of the
i-AAA protease, YME1L, decreases processing at the S2 site, indicating
constitutive cleavage of OPA1 at the S2 site by YME1L [105,113]. In
accordance with this, cells that have depleted levels of YME1L display
a highly fragmented mitochondrial phenotype. However, loss of addi-
tional YME1L functions may contribute to the altered mitochondrial
morphology. The mammalian m-AAA protease was able to cleave
OPA1 at the S1 site when both were expressed in yeast [114]. Howev-
er, depletion of them-AAA protease in mammalian cells did not stabi-
lize long forms of OPA1. Instead, it led to enhanced OPA1 processing
accompanied by increased mitochondrial fragmentation [115]. In
the absence of them-AAA protease, OMA1 was found to be the prote-
ase responsible for induced OPA1 processing [115,116]. OMA1 is a
metallopeptidase found in the mitochondrial inner membrane, origi-
nally identiﬁed in yeast due to its overlapping activity with the
m-AAA protease [18]. Experiments in OMA1-deﬁcient mouse embry-
onic ﬁbroblasts revealed that OMA1 mediates both constitutive and
stress-induced processing of OPA1 at S1 [117]. The mitochondrial net-
work appears hyperfused in OMA1-deﬁcient MEFs [117]. Further-
more, depletion of OMA1 also prevents stress-induced OPA1
processing and mitochondrial fragmentation [115,116]. OMA1 there-
fore takes center stage in monitoring mitochondrial integrity under
stress conditions, however how dysfunction of mitochondria is
sensed and how OMA1 is activated remains elusive. Stress-sensing
by OMA1 appears to be of fundamental importance under metabolic
stress conditions. Loss of OMA1 increases the susceptibility to obesity
and causes defective thermogenesis in mice accompanied by marked
metabolic alterations, suggesting that OMA1 mediates adaptive re-
sponses to different metabolic stressors [117].
3.9. Proteolytic control of mitophagy
Severe mitochondrial damage can induce the selective autophagic
removal of mitochondria by mitophagy [37,118]. Speciﬁc receptor
proteins have been identiﬁed at the mitochondrial surface, which tar-
get the general autophagic machinery to mitochondria and ensure
201R. Anand et al. / Biochimica et Biophysica Acta 1833 (2013) 195–204speciﬁcity [119–121]. A central role for the autophagic removal of
depolarized mitochondria has been assigned to the E3 ubiquitin ligase
Parkin and the PTEN-induced kinase 1 (PINK1) [122–127]. Mutations
in both genes have been associated with autosomal recessive forms of
Parkinson's disease, suggesting that accumulating dysfunctional mi-
tochondria may contribute to neurodegeneration. Strikingly, the sta-
bility of PINK1 was found to be important for the recruitment of
Parkin to depolarized mitochondria, where Parkin mediates the
ubiquitylation of mitochondrial outer membrane proteins and initi-
ates mitophagy. Thus, mitochondrial proteolysis precedes and regu-
lates the removal of severely damaged mitochondria by autophagy.
3.10. PARL regulates PINK1 stability
Nuclear-encoded PINK1 is synthesized on cytosolic ribosomes and
imported into mitochondria where it is subject to proteolytic degra-
dation (Fig. 4B) [125,128–131]. An N-terminal mitochondrial
targeting sequence directs PINK1 to mitochondria, where it is trans-
ported across the outer membrane via the TOM (translocase of
outer membrane) complex and inserted into the inner membrane in
a membrane potential dependent manner. The general mitochondrial
processing peptidase, MPP, cleaves off the mitochondrial targeting se-
quence upon import. Depletion of the ß-subunit of MPP impairs mito-
chondrial import of PINK1 pointing to an unexpected role of MPP-ß
for PINK1 biogenesis [129]. Subsequent to its integration into the
inner membrane, PINK1 is processed within its transmembrane seg-
ment by the rhomboid protease PARL, resulting in the formation of
a 52 kDa fragment of PINK1 that is further degraded by an unknown
protease (Fig. 4B) [128,130–132]. As degradation of PINK1 can be
inhibited by MG132, it is conceivable that degradation is mediated
by the 26S proteasome in the cytosol. This suggests that either the en-
tire 52 kDa fragment of PINK1 is exported from the organelle or, more
likely, incompletely imported PINK1, which remains associated with
the TOM complex in the mitochondrial outer membrane, is released
into the cytosol [133]. In vitro import assays of PINK1 in human mito-
chondria indicate that the cleaved PINK1 fragment is protease-
accessible and thus might be located on the mitochondrial outer
membrane [134]. Depletion of PARL results in stabilization of mature
PINK1 with a molecular mass of 60 kDa, which accumulates in the
mitochondrial inner membrane [130]. Despite overall compelling
support for this model (Fig. 4B), many of these localization studies
rely on overexpression of PINK1, as endogenous PINK1 is detected
poorly by the available antibodies. Indeed, some puzzling observa-
tions have been reported recently upon import of substoichiometric
amounts of PINK1 in vitro [134]. Both full-length and the 52 kDa frag-
ment of PINK1 were localized to the outer membrane and PINK1 pro-
cessing, though with strongly reduced efﬁciency, was found to occur
in mitochondria isolated from Parl−/− MEFs. Moreover, additional
peptidases, including AFG3L2, have been linked to PINK1 processing
[129]. It thus appears that the biogenesis of PINK1 is more complex
than anticipated and may still bear surprises.
3.11. Parkin mediates ubiquitylation of mitochondrial outer membrane
proteins
Loss of the mitochondrial membrane potential inhibits PINK1 im-
port into the mitochondrial inner membrane, thereby blocking its
degradation [122,125,126]. Instead, PINK1 assembles into the mito-
chondrial outer membrane and associates with the TOM complex
(Fig. 4B) [133]. Parkin is subsequently recruited to the outer mem-
brane by PINK1, a prerequisite for the initiation of mitophagy.
Upon translocation to depolarized mitochondria, Parkin mediates
K-63 or K-48 linked polyubiquitylation of outer mitochondrial mem-
brane proteins [135]. K-63 linked ubiquitylation has been proposed
to activate autophagic machinery by recruiting ubiquitin-binding
adaptors like HDACs and p62/SQSTM1 [136,137]. However, theimportance of this pathway for mitophagy has been challenged, as
cells lacking VDAC and p62/SQSTM1 have no defect in mitochondrial
turnover [138,139]. On the other hand, K-48 linked ubiquitylation by
Parkin is associated with activation of the UPS and degradation of var-
ious mitochondrial outer membrane proteins, including mitofusins,
Miro, and Tom20 [135,140–142].
UPS-dependent degradation of mitochondrial outer membrane pro-
teins precedes mitophagy but it is currently discussed controversially
whether or not it is essential for the process to occur [135].
Parkin-mediated degradation of outer mitochondrial proteins can
occur independent of mitophagy in Atg5−/− cells [143]. Moreover,
Parkin-independent pathways for mitophagy, e.g. the NIX-dependent
removal of mitochondria in reticulocytes, have been described
[146–148]. On the other hand, thewidespread proteolysis of mitochon-
drial outermembraneproteinsmight remodel themembrane andmake
it suitable for engulfment by autophagosomes [135]. Turnover of mito-
chondrial outer membrane proteins may be required to remove a neg-
ative regulator of mitophagy that is present on the mitochondrial
surface [135]. Mitochondrial fusion is inhibited upon degradation of
mitofusins allowing segregation of the dysfunctional mitochondria for
mitophagy [144]. Another substrate ubiquitylated by Parkin is the
Ca2+-dependent GTPase Miro, a component of an adaptor complex
that anchors kinesins to the mitochondrial surface to facilitate mito-
chondrial motility. Miro is phosphorylated by PINK1, ubiquitylated by
Parkin and degraded by the 26 S proteasomes [145].
Parkin-mediated ubiquitylation triggers recruitment of the
proteasome and p97 (UPS components). The presence of p97 (VCP/
Cdc48 homolog in yeast), which has a pronounced role in
ER-associated degradation (ERAD) for dislocation of ER membrane
proteins, suggests that a similar mechanism might exist for recogni-
tion and degradation of mitochondrial outer membrane proteins
[28,144,149]. The yeast protein, Vms1 (VCP/Cdc48-associated mito-
chondrial stree-responsive1) is identiﬁed as an adaptor for the
p97-orthologue Cdc48, which re-localizes to mitochondria upon mi-
tochondrial stress and stably interacts with Cdc48 [150]. Loss of
Vms1 in yeast results in impairment of ubiquitin-dependent mito-
chondrial protein degradation. Similar to Vms1, ERAD uses Npl4 and
Ufd1 for recruitment of Cdc48/p97 to the ER membrane [151]. Inter-
estingly, the Cdc48/Vms1 complex also contains Npl4 (not Ufd1)
suggesting selective sharing of critical UPS components.
4. Concluding remarks
Many mitochondrial proteases have been originally identiﬁed as
quality control enzymes that degrade misfolded or damaged proteins
and therefore protect against mitochondrial dysfunction. However, it
is becoming increasingly clear that the same proteases mediate the
processing or determine the stability of mitochondrial proteins with
regulatory functions in diverse processes, such as mitochondrial
gene expression, phospholipid homeostasis, mitochondrial dynamics
or mitophagy. Moreover, central roles of the cytosolic UPS for mito-
chondrial activities have been recognized. Proteolytic processes thus
emerge as central regulators in an interconnected network of mecha-
nisms that maintain mitochondrial activities. Impairment of mito-
chondrial proteolysis is often associated with diseases. Future
studies will be pivotal to clarify whether the impaired clearance of
damaged proteins or a general mitochondrial dysfunction underlie
such diseases.
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